This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
In United States
ADHDDrugA study involving a medication or substance.From 12 Years to 17 Years
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.